WallStreetZenWallStreetZen
Analyst Ranking
Top 3%
#115 out of 4560 analysts
Average Return
+18.62%
Win Rate
46%78 out of 168
Risk vs Reward
Poor
Good

Jay Olson's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
89bio IncETNB
+578.03%$2.64$17.90
2022-05-13 -
2023-05-12
Buy
89bio IncETNB
+450.31%$3.22$17.72
2022-06-30 -
2023-06-29
Buy
Viking Therapeutics IncVKTX
+439.77%$15.44$83.34
2023-03-28 -
2024-03-27
Buy
Madrigal Pharmaceuticals IncMDGL
+365.01%$64.44$299.65
2022-05-10 -
2023-05-09
Buy
Prothena Corp Public Ltd CoPRTA
+357.12%$12.08$55.22
2020-07-09 -
2021-07-08
Buy

Jay Olson's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Biogen IncBIIB
18Buy$270.00+39.77%Maintains
5 days ago
Sage Therapeutics IncSAGE
6Hold$17.00+31.27%Maintains
6 days ago
Revolution Medicines IncRVMD
6Buy$45.00+24.10%Maintains
12 days ago
Skye Bioscience IncSKYE
1Buy$25.00+78.19%Initiates Coverage On
12 days ago
Q32 Bio IncQTTB
1Buy$50.00+96.08%Initiates Coverage On
13 days ago
Ionis Pharmaceuticals IncIONS
3Buy$75.00+79.25%Maintains
15 days ago
Sutro Biopharma IncSTRO
4Buy$10.00+168.82%Maintains
21 days ago
Viking Therapeutics IncVKTX
7Buy$138.00+112.54%Maintains
a month ago
Cognition Therapeutics IncCGTX
4Buy$9.00+350.00%Maintains
a month ago
Madrigal Pharmaceuticals IncMDGL
7Buy$375.00+71.72%Maintains
a month ago
Neurocrine Biosciences IncNBIX
9Buy$200.00+42.77%Maintains
a month ago
Acadia Pharmaceuticals IncACAD
10Hold$19.00+13.50%Maintains
a month ago
Marinus Pharmaceuticals IncMRNS
5Hold$9.00+525.00%Maintains
2 months ago
Jasper Therapeutics IncJSPR
4Buy$80.00+261.83%Maintains
2 months ago
Immuneering CorpIMRX
1Buy$25.00+1,433.74%Reiterates
2 months ago
Prothena Corp Public Ltd CoPRTA
8Buy$80.00+289.11%Maintains
2 months ago
Amgen IncAMGN
16Buy$350.00+27.95%Reiterates
3 months ago
Biovie IncBIVI
4Buy$5.00+916.26%Maintains
5 months ago
Enanta Pharmaceuticals IncENTA
7Hold$21.00+59.70%Maintains
5 months ago
Intellia Therapeutics IncNTLA
7Buy$70.00+225.13%Maintains
5 months ago
Immunogen IncIMGN
1Hold$16.00-48.77%Initiates Coverage On
7 months ago
Exelixis IncEXEL
3Buy$29.00+24.52%Maintains
8 months ago
Crispr Therapeutics AgCRSP
5Buy$102.00+80.82%Reiterates
8 months ago
Mirati Therapeutics IncMRTX
7Buy$62.00+5.62%Maintains
8 months ago
Voyager Therapeutics IncVYGR
4Buy$16.00+109.15%Reiterates
9 months ago
Editas Medicine IncEDIT
5Hold$12.00+119.78%Reiterates
9 months ago
Incyte CorpINCY
7Buy$92.00+78.12%Reiterates
9 months ago
Galecto IncGLTO
2Buy$12.00+1,611.84%Reiterates
9 months ago
Denali Therapeutics IncDNLI
3Buy$68.00+322.10%Maintains
a year ago
Cymabay Therapeutics IncCBAY
3Buy$16.00-50.74%Maintains
a year ago
89bio IncETNB
4Buy$30.00+236.32%Reiterates
a year ago
Karuna Therapeutics IncKRTX
4Buy$280.00-15.11%Reiterates
a year ago
Bicycle Therapeutics PLCBCYC
2Buy$55.00+142.50%Reiterates
a year ago
Seagen IncSGEN
8Buy$229.00N/AMaintains
a year ago
Nektar TherapeuticsNKTR
2Hold$3.00N/AMaintains
a year ago
Cincor Pharma IncCINC
3HoldN/AN/ADowngrades
a year ago
Ayala Pharmaceuticals IncAYLA
4HoldN/AN/ADowngrades
a year ago
Relmada Therapeutics IncRLMD
2HoldN/AN/ADowngrades
2 years ago
Sierra Oncology IncSRRA
2Hold$55.00N/ADowngrades
2 years ago
Focus Financial Partners IncFOCS
1Buy$71.00N/AMaintains
3 years ago
Korro Bio IncKRRO
2Buy$20.00N/AMaintains
3 years ago
Intercept Pharmaceuticals IncICPT
1Hold$46.00N/ADowngrades
4 years ago
Tempest Therapeutics IncTPST
1Hold$2.00N/ADowngrades
4 years ago
Mediwound LtdMDWD
1Buy$84.00N/AMaintains
6 years ago
Acorda Therapeutics IncACORQ
2Hold$2,520.00N/AMaintains
6 years ago
Medicines CoMDCO
2BuyN/AN/AUpgrades
6 years ago
Neuroderm LtdNDRM
2Buy$42.00N/AUpgrades
7 years ago
Therapeuticsmd IncTXMD
1HoldN/AN/ADowngrades
7 years ago
Portola Pharmaceuticals IncPTLA
1BuyN/AN/AUpgrades
7 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.